Romiplostim
Romiplostim is a weekly injection that tells the bone marrow to make more platelets; it is approved for immune thrombocytopenia and for radiation injury, and is being tested for the low platelets that chemotherapy causes.
Overview
Romiplostim is an engineered peptibody that mimics thrombopoietin. The United States approved it in 2008 for adults with immune thrombocytopenia (ITP) who had not responded to steroids, immunoglobulins or splenectomy, later extended to children and, separately, to increase survival after acute exposure to myelosuppressive doses of radiation (haematopoietic syndrome of acute radiation syndrome). It is not approved for chemotherapy-induced thrombocytopenia, the commonest reason platelets fall in cancer care, but randomised trials in that setting are under way and haematologists use it off label when platelet counts would otherwise delay treatment.
A peptide fused to an antibody Fc fragment that binds and activates the thrombopoietin receptor MPL, increasing platelet production by megakaryocytes.
1.Romiplostim slips into a pocket on its target.
Approvals
| Region | Year | Indication |
|---|---|---|
| US | 2008 | Immune thrombocytopenia with insufficient response to corticosteroids, immunoglobulins or splenectomy · Later extended to children and to the haematopoietic syndrome of acute radiation syndrome |
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Latest papers
topQuery for this drug: (TITLE:"Romiplostim" OR ABSTRACT:"Romiplostim" OR TITLE:"Nplate" OR ABSTRACT:"Nplate" OR TITLE:"AMG 531" OR ABSTRACT:"AMG 531") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Romiplostim, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentFostamatinib
Shares Thrombocytopenia and the tags gap-fill, supportive-care.
- TreatmentRavulizumab
Shares Myelodysplastic syndromes / neoplasms (MDS) and the tags gap-fill, supportive-care.
- TreatmentEmapalumab
Shares the tags gap-fill, supportive-care.
- TreatmentPropranolol (Hemangeol)
Shares the tags gap-fill, supportive-care.
- TargetCD7
Shares Acute myeloid leukaemia and the tag gap-fill.
- TreatmentGlasdegib
Shares Acute myeloid leukaemia and the tag gap-fill.
- TreatmentPivekimab sunirine
Shares Acute myeloid leukaemia and the tag gap-fill.
- TreatmentLuspatercept
Shares Myelodysplastic syndromes / neoplasms (MDS) and the tag gap-fill.